Research and Development

In the last 10 years, pharma’s relationship with the NHS has undergone a transformation. For one thing, it’s difficult now …

Most marketers in the pharma industry understand the need to get alongside and talk to key people in the NHS …

Pioneering British stem cell research company ReNeuron has bought the Californian company, AmCyte – a move it hopes will make …

BioMS's multiple sclerosis trial gets positive reviewBioMS Medical's relapsing-remitting multiple sclerosis trial has received a positive review from the data …

Lilly has opened a new extension to its UK drug research laboratories which specialise in new medicines for neurological conditions.The …

Affiris begins clinical testing of Alzheimer's vaccineAffiris' Alzheimer's vaccine Affitope has now entered the clinical phase of its development and …

Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …

There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …

Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …

Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …

Biovest reports encouraging interim results for cancer vaccineBiovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, has revealed positive interim data …

The global clinical trials market continues to grow and is currently worth an estimated $10 billion; so much so that …

Roche has added a novel treatment for rheumatoid arthritis to its early stage pipeline, one it says has the potential …

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …

The largest new imaging centre in Europe – an £83 million collaboration between GlaxoSmithKline (GSK), Imperial College London and the …